Estimates of a recent yearly incidence of 400 000 cases of paralytic poliomyelitis, 2-5 million deaths from measles and its complications, over 1 million deaths from neonatal tetanus, and 735 000 deaths from pertussis in Asia, Africa, and Latin America now pose a greater challenge for new action than did the worldwide eradication of smallpox several years ago. By virtue of the conditions obtaining in the developing countries mere expansion or acceleration of what is being done now-even with modifications that may achieve a temporary increase in vaccine coverage-cannot achieve the desired rapid elimination and continuing control of these diseases.
Introduction
Diseases of early childhood preventable by vaccination remain a serious public health problem in many countries in Asia, Africa, and Latin America despite the continuing increase in the proportion of children receiving effective available vaccines. It is well known that the numbers of reported cases of measles in all countries' and of paralytic poliomyelitis in developing countries' seriously underestimate the actual number. Estimates of the World Health Organisation for 1983, however, suggest that in the developing countries there were probably about 400000 cases of persisting paralytic polio, 2-5 million deaths attributable to measles and its complications, over 1 million deaths from neonatal tetanus (which can be prevented only by immunization of women of childbearing age), and about 735 000 deaths attributable to pertussis, predominantly during the first year of life.' With the birth of over 100 million children in the developing countries every year the number paralysed by polio may increase by 4 million during the next 10 years, and the annual number of deaths from the other vaccine preventable diseases may remain unchanged if the procedure of immunising children in developing countries is not modified wherever possible, as soon as possible.
The present procedure of immunising children in the developing countries is Marranzini, personal communication, 1985) .
In Brazil, where routine reporting, with all its inadequacies, has shown the extraordinary impact of the annual national days ofantipolio vaccination, the ultimate measure of effectiveness would come from properly performed surveys of lameness among children of different ageslo-for example, those born in 1971, 1976, and 1981-before and after the annual national days of vaccination.
Strategy for measles
Theoretically, it should also be possible to achieve rapid elimination and continuing control of measles by bringing the vaccine to the children during national annual days of vaccination. An initial break in the chain of transmission of measles virus should appear within a few weeks after a proper mass vaccination, which would be followed by yearly vaccination only of the new generations of children. But how are we to achieve that initial rapid break in the chain of transmission of measles virus? In October 1985 I analysed four Brazilian states with a combined population of 63 million and found that antimeasles vaccination of millions of previously unvaccinated children under 5 during the annual national days of antipolio vaccination in 1984 and 1985 had not prevented the continued occurrence of thousands of hospitalised cases of measles during the subsequent months. Only in the state of Rio de Janeiro was there an unprecedented, immediate pronounced drop in hospitalised cases. There, however, a separate mass campaign of measles vaccination had been carried out on a single day (11 May 1985) , for all children from 9 to 59 months of age and without reference to a history of measles or measles vaccination.
But it was evident that even that strategy was not enough to break the chain of transmission. On the basis of available data the following five steps may be needed in a strategy for the rapid elimination and continuing control of measles in developing countries.
Step 1-Establish the well organised auxiliary army of community health volunteers needed for the annual national programme of antipolio vaccination and test its operational efficacy during at least two national days of vaccination.
Step 2-Select a number of hospitals to which children with measles or its complications are admitted and make certain that proper records are kept as a source of monthly data for morbidity and mortality attributable to measles.
Step 3-Determine the age distribution in the hospitalised cases during the preceding five years as a basis for selecting the age groups to be included in the first national day of vaccination against measles.
Step 4-During the first year of the antimeasles vaccination campaign set aside one or more days (at least one month before the usual seasonal rise in measles) only for vaccination against measles of all children in the age group found to account for about 95% of the hospitalised cases, and make no exception because of a previous history of measles or measles vaccination. The large auxiliary army of community health volunteers-augmented when necessary by additional, specially trained volunteers-may serve either at fixed vaccination posts within easy walking distance, as members of mobile teams, or as home vaccinators depending on the conditions for a given region. Where school age children need to be included in the initial campaign select a procedure best suited for the region. Including children with a history of measles (because of uncertainty of diagnosis) or measles vaccination (because of uncertainty of proper refrigeration of the vaccine used or the age at which it was given) will greatly increase the amount of vaccine needed for the initial programme designed to break the chain of transmission, but there is a high probability that this will be unavoidable unless experience provides contrary evidence.
Step 5-During subsequent years, when most of the children requiring measles vaccine would be those who were too young for vaccination during the initial campaign, the measles and polio vaccines could be given at the same time, in the same place, on the same annual national day of vaccination.
The point has rightly been made that while it is easy to train thousands of non-professional community volunteers to give two drops of oral poliomyelitis vaccine by mouth, giving measles vaccine by subcutaneous injection is much more difficult. Although already there has been practical experience, especially in Brazil, in which millions of children have received oral poliomyelitis vaccine by mouth and measles vaccine by injection during the same national days of vaccination, the injections were mostly given by specially recruited and trained medical and nursing students-and there would not be enough of these in many parts of the world. The finding that a 30 second inhalation of an aerosol of currently available chick embryo measles vaccine can immunise all children aged 7 months and over'" could be put to practical use in vaccination posts (fixed or mobile): only an inexpensive foot pump to produce the aerosol and disposable, perforated waxed paper liners for the masks would be required. This procedure may not be practicable for individual vaccinators who take the vaccines to the homes of the children. I believe that it would not be difficult to teach nonprofessional community volunteers to use the single dose, disposable polyethylene phials with attached needles (Ezeject) which were patented and approved for general use in 1978.12 A special initiative by the WHO might induce pharmaceutical companies to supply measles, combined diphtheriapertussis-tetanus, and tetanus toxoids in the Ezeject system at a cost that would be acceptable for annual national programmes of vaccination in developing countries.
Neonatal tetanus
In countries where neonatal tetanus continues to be a serious public health problem'3 14 prevention of neonatal mortality from this cause would be greatly enhanced by vaccination of women of childbearing age during the annual national days of vaccination.
Pertussis and diphtheria
Although extensive use ofcombined vaccine against diphtheria, pertussis, and tetanus may be expected greatly to reduce morbidity and mortality from pertussis, eradication of this disease is less likely than that of measles, partly because vaccine efficacy is often low'5 and because successful vaccination does not prevent people from becoming healthy carriers of the infection.
For diphtheria, which often occurs as a mild skin infection in developing countries, there is inadequate information on the magnitude of the problem of the life threatening pharyngeal disease.
Conclusion
In 
